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Purpose
The purpose of this document is to provide a summary of the research undertaken during 
the project, ‘Evidence based approaches to emotional well-being’. The contents of this 
document include potential actions/recommendations highlighted by the research phase of 
the project, which The Landuu Company may wish to comment on. The remainder of this 
paper discusses key aspects of the project in further detail, covering the project’s 
background and approach, key findings, an options appraisal, equality, diversity and privacy 
implications and recommendations. The paper concludes with a summary of the 
information presented within this document.   
Actions/Recommendation
The project team recommends The Landuu Company:
a) Review its current service offering with reference to the narrative review attached; 
Some but not all therapies contained in the project definition document are 
considered by Charities on their webpages and / or research teams.  Identifying 
these therapies against the current service map will point to gaps of information in 
the wider community.
b) Consider the implications of group intervention (if not offered already), as an avenue
for social support; group definition may extend to include healthy individuals that 
support the individual with cancer.
c) Explore opportunities to establish feasibility / pilot studies that examine practices 
offered by the company not yet in the research literature.
d) Canvas local business to map diversity of skills for interventions to consider 
networking for the future.
1. Background
1.1 Following receipt of the project brief, the project team produced the PDD, 
analysing the project requirements and identifying the outputs and the key 
milestones.
1.2 After an initial search yielded sparse results, the project team met with the Landuu 
Company to define a wider scope to the project regarding search terms and 
redrafted the PDD.
1.3 This PDD was approved on 24th July 2019, confirming the details of the contract 
between the company and the project team.
1.4 The project is responsible for researching effective approaches to emotional 
wellbeing, with specific reference to impact during the treatment of cancer. This 
was to be completed via an analysis of peer reviewed academic sources and the top
five cancer charity websites. 
2. Approach
2.1 The key search terms of the PDD were used to search the webpages of the UK’s top
five cancer charity websites. A systematic literature search was  conducted using 
the key search terms and associated synonyms as suggested by the database (see 
annexed report, appendix 1), with results filtered according to parameters set for 
the scope of the project (see annexed report, appendix 2).    Results were collated 
and formalised into a report consisting of two sections (annexed).
3. Key Findings
3.1 Cancer charities are aware of some of the complementary and alternative therapies
(CAM) offered by the company, but not all.  Research papers reflect this partial 
coverage.
3.2 The literature review suggests that use of the covered complementary therapies is 
safe both pre-, during and post traditional treatment for cancer. 
3.3 Summary effects sizes for studies within the literature review range from null to 
large; RCT studies find small to null effects and appear to be the most rigorous 
study design to detect effects. Cancer charities are aware of this sparse evidence 
base and stipulate the need for more research for a stronger evidence base by 
which to discuss complementary therapies as an unequivocally positive and 
additional method for treating cancer and its secondary effects.
3.4 Emotional well-being in individuals with a cancer diagnosis does not appear to be 
regarded as its own domain independent of depression or anxiety across the five 
cancer charities. This is also echoed by the literature review with most studies 
measuring emotional well-being and / or depression and / or anxiety.  Quality of 
life is a validated index within research, measured by several assessment 
instruments (see annexed report, appendix 4) and is used in cancer websites; 
emotional well-being as a construct is nested within this larger concept.
3.5 The cancer charities seem to focus upon individual treatments, while the literature 
review studies include group-based treatments.  One charity extends the idea of 
therapy provision to those who care for people with cancer.
3.6 Investigation into CAM through the use of randomised controlled trials has evolved 
over time with some evidence to suggest that studies are attempting to separate 
out the active elements of discrete therapies through careful choice of a contrast 
treatment group as well as using passive control groups such as standard care or 
wait-list conditions.  
3.7 There is some concern within the charity literature that further normalisation of 
the language and terminology surrounding complementary therapies is needed.
4. Options Appraisal
4.1 This section appraises three options, listed below, that reflect the levels of 
engagement that the company could choose in using the report findings.  Each level
contains a possible outcome of how the company may act and the project team 
suggests the benefits and dis-benefits of this example. Progression through the  
represents an accumulation of actions.
4.2 Do nothing: maintain practice as before the implementation of the project brief.  
i. Benefit: Clear focus on the company’s mission to provide a personal and 
individualised service to their clients.
ii. Dis-benefit: missed opportunity to examine broader service models that  
can complement the individualised provision with models that reflect 
social support aims.
4.3 Do the minimum:  Read the final report and add the report findings for each 
discrete complementary therapy onto their own provision map.
i. Benefit: Personal level of knowledge against the original research aim is 
changed. This could inform client consultations on an ad hoc basis.
ii. Benefit: Company level of knowledge – the enriched company provision 
map would signpost the services that are actively promoted and 
researched in the wider community and reveal gaps where objective and 
verified knowledge needs attention.
iii. Dis-benefit: the project team cannot identify a dis-benefit to the minimum 
action option
4.4 Do something: Explore the feasiblity of regularly timed, group-based interventions 
as an additional, complementary provision.
i. Benefit: a diluted investment of time could be more manageable for a 
wider client group.
ii. Benefit: a wider provision may demand a search for additional, local 
practitioners – networking could be very positive for long term 
development.
iii. Benefit: group-based interventions can feed into individual consultations 
as a progression in care or represent a ‘next stage’ of continuing care for 
clients who have completed provision at the individual level of service.
iv. Dis-benefit: such an addition may reduce the availability of people who 
provide the individualised service while timetables adjust to weekly 
session.
v. Dis-benefit: assuring the quality of any additional practitioners has time 
and costs implications.
vi. Dis-benefit: assembling groups in regular meetings has transport and 
accommodation implications (e.g. car parking / size of room) which could 
incur further costs during set-up process.
5. Equality, diversity and privacy implications
5.1 While an impact assessment was not undertaken as a part of this project, the 
project team do not foresee any issues pertaining to equality, diversity and privacy 
with the findings of this report. This is due to all of the information reviewed being 
either peer-reviewed articles or publically available online resources. However, 
some of the project’s recommendations may require The Landuu Company to 
consider equality, diversity and privacy implications, if recommendations were to 
be actioned.  
6. Recommendations
6.1 There is potential to grow the client base by offering weekly group-based 
interventions (models suggested in RCT studies) and to consider including members
of the target client’s support network, e.g. formal / informal carers, family 
members or friends. 
6.2 Close consideration of a patient’s background may be beneficial in tailoring The 
Landuu Company’s services to better suit patient needs. For example, a 
consideration of whether a patient would benefit from alternative therapies 
involving a spiritual advisor may be beneficial.
6.3 Consider implementing pre- and post- measurement of client emotional well-
being / depression / anxiety as they engage with the company’s services in order to
build an additional base of evidence that complements the qualitative nature of 
client testimonial.
6.4 Increased attempts to inform and normalise language employed in the discussion 
of CAM may be beneficial in encouraging patients to try new therapies. This was 
noted as particularly problematic for patients who have been advised to undertake 
talking therapies. 
6.5 All of the above recommendations would require The Landuu Company to gain a 
significant amount of personal information from patients. In this respect, equality, 
diversity and privacy implications may need to be considered.  
7. Summary
7.1 In summary, this paper has offered a brief action to be considered by The Landuu 
Company. The paper gives a brief background to the project, discussing the 
approach to the project, key findings emerging from the narrative review 
conducted during the project, offers details regarding an options appraisal, along 
with considerations of equality, diversity and privacy implications. The paper 
concludes by offering five recommendations for The Landuu Company to consider. 
8. Annexes
Emotional Well-Being for People with Cancer: Narrative review of charity sector 
resources and peer-reviewed articles for effects of complementary interventions
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Introduction
Additional to the primary health concerns for an individual with cancer are secondary
symptoms that can manifest as feelings of reduced emotional well-being, increased 
feelings of depression or anxiety.  While chemotherapy and radiotherapy form the 
nexus of traditional treatment, many individuals use complementary or alternative 
therapies (CAM) to manage these secondary health issues.   The following report 
contains two sections.  The first section details the content of five UK cancer charity 
webpages with respect to complementary or alternative therapies. The second 
section describes the results of a systematic literature review of peer-reviewed 
articles studying the effects of CAM in patients with cancer since over the last fifteen 
years.
Macmillan Cancer Support offers the following definition, which will be used 
throughout this report:
Conventional medical treatments are used by doctors to treat people with 
cancer. They include surgery, radiotherapy, chemotherapy, hormonal and 
targeted therapies. These treatments are scientifically tested and researched. 
They can cure many cancers, help people to live longer or reduce their 
symptoms...complementary therapies are used alongside, or in addition to, 
conventional medical treatments. They do not claim to cure cancer. People 
use them to boost their physical or emotional health. Or to relieve symptoms 
or side effects. Some have been scientifically tested to check how effective 
and safe they are...alternative therapies are used instead of conventional 
medical treatments. They are not tested in the same way as conventional 
medical treatments. Some claim to treat or cure cancer. But no alternative 






The purpose of this review is to supply The Landuu Company with a detailed 
account of the information available from the top five UK cancer charities with 
respect to the use of complementary and alternative therapies (CAM) that may be 
available to cancer patients. 
Cancer Research UK shows that nearly ‘30-40% of people with cancer use (CAM).  
The American Cancer Society list the most common forms of CAM as prayer or 
spiritual practice, relaxation, faith or spiritual healing or nutritional supplements and 
vitamins.  Cancer Research UK’s materials includes a discussion of why people may
choose to use CAM when dealing with cancer. They suggest that ‘many patients like 
the idea that complementary therapies seem natural and non toxic’, while also noting
that other aspects, similar to those discussed within the literature pertaining to 
depression, which may also help to make people feel better (for example, ‘touch, talk




Rb2REUWtPTVE).  Research found, however, that this varied between the differing 
backgrounds of patients and the types of cancer diagnoses that they had received.  
While CAM can be useful in making patients feel better and more in control while 
helping them to cope with cancer, ‘There is no evidence to suggest that any type of 





Cancer Research UK calls for additional research into CAM for people with cancer in
order to: understand how they work and check if they are safe to use; find out if they 
interact with conventional medicine and how; check whether specific therapies work 
and do what they claim to do; test them against accepted treatments to see if they 
work as well or better; learn if they improve quality of life for people with cancer [and]








This review details the online information available for CAM from the top five UK 
cancer charities, as listed by The Guardian1, using search criteria specified within the
1  The link for this Guardian article has expired since the original search and finalising 
the report
Project Definition Document. The top five cancer charities in the UK were identified 
as: Cancer Research UK, Macmillan Cancer Support, Marie Curie Cancer Care, The
Royal Marsden Cancer Charity and Bloodwise (formally Leukaemia and Lymphoma 
Research). The goals of each charity reviewed are as follows:
 Cancer Research UK suggests that it is ‘the world’s largest charity dedicated 
to saving lives through research.’ Their ‘vision is to bring forward the day 
when all cancers are cured’ ( www.cancerresearchuk.org/  ).
 Macmillan Cancer Support (hereafter Macmillan) states that, ‘Whatever 
cancer throws your way, we’re right there with you. We provide physical, 
financial and emotional support to help you live life as fully as you can’ 
(https://www.macmillan.org.uk/).
 Marie Curie Cancer Care states that they offer ‘free, practical information and 
emotional support for anyone affected by terminal illness, when it’s needed 
most’ (www.mariecurie.org.uk/).
 The Royal Marsden Cancer Charity notes that, ‘The Royal Marsden Cancer 
Charity raises money solely to support The Royal Marsden, a world-leading 
cancer centre’ (www.royalmarsden.org/about-us).
 Bloodwise suggests that their charity is ‘here to beat blood cancer’. They 
stipulate that ‘blood cancer is the UK’s third biggest killer’ 
(bloodwise.org.uk/about).
Each website was searched for materials found under the following key terms: 
depression, anxiety, therapy, emotional well-being and emotional resilience. This 
produced seventy-five separate webpage results, following the removal of duplicate 
webpages returned as a result of using several key search terms. The content of the 
seventy-five relevant pages was then coded using the key search terms to highlight 
similarities and differences between the information offered by each charity. 
Each of the following sections explores the online content offered with reference to 
depression and anxeity and the associations pertaining to emotional well-being, 
emotional resilience and therapy. The remainder of this review follows a similar 
fashion, including sections associated with the terminology used during the key word
search to explore similarities and differences across the literature provided by the top
five cancer charities in the UK. 
Depression
Depression and emotional well-being
Cancer Research UK suggests options for treating depression such as: ‘seeing your 




RmRTVGhRb2REUWtPTVE). Similarly, Macmillan suggests that, emotional well-
being is a significant factor in dealing with a cancer diagnosis, noting aspects such 
as ‘who can help’ and ‘managing day-to-day life’. Furthermore, Macmillan also offers 
advice for carers, including young-carers, of people with cancer and for anyone who 
knows a person with cancer (www.macmillan.org.uk/information-and-support/coping/
your-emotions).
Cancer Research UK and Macmillan note a range of emotions, for example, shock, 
denial, fear, anxiety, panic, guilt, blame, anger, sadness, feeling alone and 
depression which the charities seek to normalize as emotional responses to a cancer
diagnosis. Additionally, Cancer Research UK suggests that ‘trying to stay positive’ 




b2REUWtPTVE).   Both charities suggest a range of options to facilitate emotional 
well-being. For example, Macmillan notes that emotional and practical support may 
be required for patients dealing with cancer pain. The charity suggests that ‘pain can 
affect many aspects of your life including your body, thoughts and feelings’. This may
also include spiritual pain 
(www.mariecurie.org.uk/help/support/terminal-illness/wellbeing/emotional-spiritual-
pain). Macmillan further suggests that talking is a good way to cope with emotional 
destress brought on by a cancer diagnosis, with GPs, cancer support specialists, 
support groups, religious or spiritual leaders and counselling organizations being 
suggested as good starting points 
(www.macmillan.org.uk/information-and-support/coping/side-effects-and-symptoms/
pain/getting-emotional-and-practical-support.html). Macmillan cites a clinical trial of 
singing as a method for improving one’s emotional state: ‘A study looking at choir 
singing as a way to improve people’s well-being’. Results suggest that singing in a 
choir for one hour a week, for upto 12 weeks can ‘improve your mood...reduce the 





Although absent from Cancer Research UK’s website, Macmillan also details 
suggestions for individuals who know or are caring for someone with cancer. The 
charity notes that the feelings experienced by patients of a cancer diagnosis, may 
also be applicable to those who know them or are involved with their care. This, 
Macmillan suggests, is also a normal response to the situation. Similar to the advice 
offered to those with cancer diagnoses, Macmillan suggests that talking (for 
example, to family, friends or a doctor) is a good starting point to managing the 
emotions brought on by a cancer diagnoses in a supporting individual 
(www.macmillan.org.uk/information-and-support/coping/your-emotions/dealing-with-
your-emotions/cancer-and-your-feelings.html). 
Suggestions for support for carers is further broken down, offering further guidance 
for those adults and young people. The charity suggests that writing down feelings 
might be a good coping mechanism for addressing emotional distress while again 
emphasising that negative emotions are normal in such situations 
(www.macmillan.org.uk/information-and-support/coping/your-emotions/if-you-are-a-
young-carer/your-emotions.html). Macmillan further suggests that young carers 
should take care to look after themselves, particularly if they ‘feel overwhelmed by 
the situation’ (www.macmillan.org.uk/information-and-support/coping/your-emotions/
if-you-are-a-young-carer/getting-emotional-support.html). This, Macmillan notes, may
be achieved by talking to someone such as those in similar situations, or by asking 
an advocate to discuss issues with teachers, professionals or other stakeholders on 
their behalf. 
Further advice from Macmillan suggests finding a website or organization that could 
help, letting school, college or work know about the situation in order to gain any 
additional help, support or time off that might be needed, making time for the things 
that they enjoy and letting people know if they are uncomfortable with any of the 
duties associated with caring for someone with cancer, as alternative assistance for 
the patient could be sought 
(www.macmillan.org.uk/information-and-support/coping/your-emotions/if-you-are-a-
young-carer/getting-emotional-support.html).
Ultimately, both Cancer Research UK and Macmillan suggest that a wide range of 
negative feelings may arise from a cancer diagnosis. Indeed, both charities suggest 
that depression is a possible outcome and that emotional well-being could be 
important for people living with cancer and those caring for them. However, 
Macmillan notes that, ‘the way you feel can influence the way you cope with cancer 
and its treatment. But there is no evidence that feelings can affect the cancer itself’ 
(www.macmillan.org.uk/information-and-support/coping/your-emotions/dealing-with-
your-emotions/cancer-and-your-feelings.html). 
   
Depression and emotional resilience
Cancer Research UK offers details of a treatment programme ‘which offer patients 
one-to-one sessions with specially trained cancer nurses to help them manage their 
depression more effectively’. The charity found that ‘after three months of receiving 
the new treatment, almost 20% fewer patients were depressed compared with 
patients who received standard NHS treatment. The difference was still evident after 
one year’. During the trial stage of the treatment, half of participants were offered 
standard care for individuals facing depression from their GP or specialists. ‘The 
other half received the special programme which entailed sessions on: 
understanding depression and the effects of anti-depressants; problem-solving 
therapy to help patients overcome feelings of helplessness; liaison with oncologist 
and GP to collaborate in treatment of depression; monthly monitoring of progress by 
telephone and providing optional “booster” sessions’. After three months of 
treatment, measures demonstrated improvements in anxiety and fatigue, in addition 




Rb2REUWtPTVE). The inclusion of this study suggests supportive evidence that 
treatment option of talking (as detailed in the above section ‘depression and 
emotional well-being’) is being further explored and shows promising results. 
However, there is also the possibility that such findings could be explained by 
patients receiving additional social interaction and support, rather than findings being
solely based upon the impact of the therapy alone. 
Depression and therapy 
Cancer Research UK notes that researchers are currently looking at improving ways 
to help to treat depression in cancer patents. According to the charity, recent projects
include exploration into; ‘how advanced cancer affects depression; how cognitive 
behavioural therapy can help people with advanced cancer; how long treatments for 
depression should be; differences between support from specialist nurses and 
counsellors; how changes to your body can affect depression; having depression 




Rb2REUWtPTVE). While such research is still ongoing, advice available from the top
five cancer charities online suggests a range of potential treatment options. 
One such treatment is that of herbal medicines, a complementary approach which 
uses ‘plants, or mixtures of plant extracts, to treat illness and promote health’, 
however, further scientific evidence is required to show benefits for cancer patients.  
‘Herbal medicine aims to restore your body, so that it can protect, regulate and heal 
itself’, with the two most common types of herbal medicine being those of Western 
herbal medicine, which ‘focuses on the whole person rather than their illness’, and 
Chinese herbal medicine, which ‘aims to restore the balance of your Qi’. Herbal 
medicines are a common therapy used by individuals with cancer, with ‘as many as 





In addition, Cancer Research UK suggests St John’s wort as, ‘a herbal remedy used 
as a complementary therapy for mild to moderate depression’, however, it also notes
that there is the potential that St John’s wort could ‘interact with cancer drugs and 
other medication’, such as irinotecan, docetaxel or imatinib. The charity suggests 
that St John’s wort has previously been reported ‘as a wonder drug to treat 
depression and help people to feel better’. Cancer Research UK notes that people 
often use St John’s wort to attempt to treat depression, rather than discussing 
problems with trained medical staff, however, guidance offered by the charity does 
point towards the benefits of talking to a doctor or nurse about issues (and before 




b2REUWtPTVE).    
Homeopathy is another area explored in depth by Cancer Research UK, with 
homeopathy using ‘small doses of a substance that in large doses would cause 
symptoms of the illness’. However, Cancer Research UK states that there is no 
scientific evidence to support homeopathy as a cure or preventive method for 
cancer. It also states that it may interact with other medicines.
Despite Cancer Research UK’s assertion that homeopathy is not a cure or 
preventive therapy for cancer; homeopathy ‘is [still] one of the most common 
complementary therapies used by people with cancer’, as ‘followers believe that 
homeopathic medicines work by starting the body’s self-healing process’, during 
which ‘the body tries to keep a stable internal environment’. Homeopathy is used by 
cancer patients as it ‘may help them feel better or more in control of their situation’ 
and it can be used in addition to conventional medical treatments. Cancer Research 
UK suggests its users believe it to improve: relaxation, coping with stress, anxiety 
and depression and controlling symptoms/side effects like pain, sickness and 
tiredness. However, this may be due to the placebo effect and in 2010 the UK 






Taking a different approach, Cancer Research UK further suggests that ‘talking 
therapies’ may also be beneficial in treating depression for individuals with a cancer 
diagnosis. The charity notes that while some patients may find ‘counselling’, 
‘psychotherapy’ or other related terminology off-putting, discussing issues with a 
therapist can be a helpful tool in tackling depression. The charity attempts to 
normalise seeking this form of intervention through a discussion of reasons as to 
why an individual might seek this form of treatment (e.g. phobias, panic attacks or 
sleeping disorders). Further advice details the different types of therapists 
(counsellor, psychotherapist, psychologist and psychiatrist) that patients may come 
into contact with and notes the importance of feeling comfortable with the chosen 





Cancer Research UK describes counselling as ‘talking to a trained person 
(counsellor) and exploring problems or issues in a safe and supportive environment’,
while cognitive behavioural therapy (CBT) ‘aims to help you change how you 
respond to certain situations or emotions. It helps you understand how your thought 
patterns may be contributing to your feelings of depression or fear’, while also 
teaching control and calmness for body and mind. Psychotherapy is described as 
involving ‘talking to a trained therapist, although sometimes other methods may be 
used such as music or art’. The purpose is to allow patients an in-depth look at 
‘problems and worries, and deal with problems such as depression or fear’. Cancer 
Research UK further emphasises that it is possible to combine anti-depressants and 





Further evidence of the potential benefits of ‘talking cures’ can be found in a Cancer 
Research UK press release, which suggests that talking (in this case to cancer 
nurses) ‘eases chronic insomnia in cancer patients’. However, it is important to note 






In a similar vein, managing personal emotions is also seen as a key area for patients
with a cancer diagnosis, according to the materials available online from Cancer 
Research UK. Suggestions include; ‘taking each day as it comes, exercise, eating 
well, avoiding alcohol and drugs, relaxation techniques, talking to other people, 
drawing or keeping a journal (and) reading about your feelings’. Similarly to 
previously discussed material within this subsection, Cancer Research UK again 
emphasises that patients may need to cope with sleep problems, suggesting that 





Further advice includes the importance of controlling symptoms (i.e. ‘The better you 
feel physically, the more help it will be in coping with your feelings or with 
depression’), learning to live with cancer, which the charity suggests can take a 
significant amount of time to get used to, looking well but not feeling well which may 
be impacted by the recovery time required and if others expect patients to complete 
certain tasks which they may not feel ready for. Finally, Cancer Research UK 
suggests that worrying about cancer returning can be a significant issue. The charity 
notes that this can be difficult to come to terms with and suggests talking treatments 




Increasing attention appears to be being paid to the potential benefits of Art 
Therapy’s ability to ease pain for cancer patients.  For example, materials from 
Cancer Research UK notes a study that aimed to explore the impact of ‘using art 
therapy to help with pain after breast cancer treatment’ and the intervention’s 
capacity to ‘change the experience of pain’, in addition to monitoring patients ‘pain 
score and use of painkillers’. The study ‘involved 50 cancer patients over a four-
month period and aimed to relieve symptoms such as pain, tiredness, nausea, 
depression, anxiety, drowsiness, lack of appetite, general well-being and shortness 
of breath’. The results were positive for eight out of nine symptoms, the exception 
being symptoms of nausea, as measured by the Edmonton Symptom Assessment 
Scale (ESAS).   This was viewed as being due to offering patients ‘a means of 




b2REUWtPTVE).  There is sparse empirical evidence to support art therapy as 
beneficial for cancer patients, however, and Cancer Research UK concedes that 
further research is still required.
Massage therapy is another CAM identified as potentially of benefit for cancer 
patients by both  Cancer Research UK and Macmillan Cancer Support. Cancer 
Research UK notes that, ‘Massage is an ancient therapy that works by stroking, 
kneading, tapping or pressing the soft tissues of the body’, however, advice does 
state that ‘there is no scientific evidence that massage can treat cancer’.  Several 
types of massage are listed by the charity (Swedish, aromatherapy, deep tissue, 
sports, shiatsu and neuromuscular) which are promoted as a way to improve mood 
and sleep, enhance well-being and as a coping mechanism for stress, anxiety, 
headaches and pain. Macmillan adds a benefit for those individuals experiencing 
breathing difficulties (www.macmillan.org.uk/information-and-support/mesothelioma/
pleural-mesothelioma/treating/supportive-therapies). Both charities advise against 
deep tissue massage even though it confirms that no research has proven the 
assertion that ‘having a massage when you have cancer may make the cancer cells 
travel to other parts of the body’. Furthermore, Cancer Research UK suggests that 
massage therapy should be avoided on areas of the body undergoing radiotherapy 





In addition to massage therapy, Cancer Research UK suggests that exercise therapy
may be beneficial for cancer patients. One trial study examined whether ‘exercise 
would help improve quality of life and reduce feelings of fatigue, anxiety and 
depression’ with particular focus upon ‘how the treatment affected people physically, 
mentally and emotionally’. Despite promising results, a further, larger scale trial was 





Relaxation also features as a CAM.  A separate trial described by Cancer Research 
UK explored ‘relaxation therapy and guided imagery for people with bowel cancer’. 
The study examined ‘the effect of relaxation and guided imagery on patients 
undertaking chemotherapy to explore any potential benefits to quality of life’. Cancer 
research UK describes guided imagery as, for example, imagining your body being 
healthy or as attacking cancer cells.  The results of the study demonstrated no 





Meditation is also listed by Cancer Research UK as a method by which people with a
cancer diagnosis can try to calm and relax their minds and bodies. Guidance 
suggests that people with cancer use meditation as it can help to reduce anxiety and
stress while also helping to ‘control’ problems such as; ‘pain, difficulty sleeping, 
tiredness, feeling sick [and] high blood pressure’. Cancer Research UK suggests that
meditation can be led by ‘people who have training in practising and teaching 
meditation, doctors and nurses, psychiatrists, psychologists and other mental health 
professions [and] yoga teachers’. Advice from the charity also suggests that 
individuals can practice meditation by themselves at home and that meditation can 
be undertaken individually or as part of a group. The different types of meditation 
mentioned by Cancer Research UK include; ‘mindfulness meditation, mindfulness 
based stress reduction (MBSR), focused meditation, visualisation and guided 
imagery, transcendental meditation, prayerful meditation [and] meditation and 
movement’. Indeed, while typically small scale, studies suggest that meditation 
(particularly MBSR) might be beneficial in improving mood and concentrations, 





An additional therapy discussed by Cancer Research UK is healing. ‘Healers believe
that healing energy exists all around us, and that they can channel this energy’ to 
heal others. Again, Cancer Research UK states that there is no scientific evidence 
supporting healing as a treatment for cancer. Beliefs about healing include various 
strengths of ‘universal energy’ and some believe that ‘love and care create energy. 
This can encourage your spirit to change the process of your disease physically. So, 
for example, it can shrink a tumour’. Different types of healing include; contact 
healing, therapeutic touch, absent healing and faith healing. Healers suggest healing
as a natural way to relax and cope with issues such as; stress, anxiety, depression, 






Anxiety and emotional well-being
Both Bloodwise and Macmillan discuss coping with anxiety and the importance of 
emotional well-being in the information they provide for individuals with a cancer 
diagnosis. For example, information provided by Bloodwise suggests that some 
people with blood cancer may not need immediate treatment. Instead, symptoms are
monitored, a process often called ‘watch and wait’, ‘active surveillance’ or ‘watchful 
waiting’. In cases where ‘watch and wait’ is applicable, the charity suggests that the 
following could be beneficial in dealing with anxiety surrounding the situation: talk to 
people you care about, look for peer support, make use of support organisations, 
appreciate good things, take each day as it comes, look after yourself, stay active, 
access counselling if needed, trust healthcare professionals and do what works for 
you (www.bloodwise.org.uk/community/how-to-cope-anxiety-blood-cancer-watch-
wait).
While advice from Bloodlines refers to dealing with anxiety in relation to a specific 
type of cancer, information from Macmillan is more generalised. Similar to previously
discussed information from Cancer Research UK, Macmillan suggests talking to 
those close to you, discussing concerns with health care professionals and 
discussing issues with others in similar situations as good methods in dealing with 
anxiety. Additionally, the charity suggests that writing may also be beneficial. Other 
advice offered by Macmillan includes: relaxation exercises, cutting down alcohol and 
caffeine, getting enough sleep, exercising regularly, using imagery meditation or 
mindfulness and using complementary therapies like massage or aromatherapy 
(www.macmillan.org.uk/information-and-support/coping/changes-to-appearance-
and-body-image/body-image-after-treatment/changes-to-your-body.html). However, 
specifics as to which type of massage are not discussed here, unlike the earlier 
information from Cancer Research UK. 
Furthermore, Macmillan includes information for individuals with a cancer diagnosis 
on relaxation techniques. For example, guidance is offered about how to relax when 
experiencing breathlessness 
(www.macmillan.org.uk/information-and-support/coping/side-effects-and-symptoms/
breathlessness/relaxation-techniques.html). Macmillan also provides information 
pertaining to lifestyle choices and well-being, for improvement of long-term health.  
They include aspects such as: stopping smoking, being more physically active, 
eating healthily and maintaining a healthy weight, limiting alcohol consumption and 
doing enjoyable activities with family and friends (www.macmillan.org.uk/information-
and-support/treating/after-treatment/recovery/lifestyle-and-well-being.html). 
Anxiety and therapy 
Marie Curie suggests there is some cross-over between symptoms and treatments 
for anxiety and depression 
(www.mariecurie.org.uk/help/support/terminal-illness/wellbeing/depression-anxiety ) with 
one such aspect being providing emotional care to individuals dealing with a cancer 
diagnosis (https://www.mariecurie.org.uk/professionals/palliative-care-knowledge-zone/
individual-needs/psychological-needs). 
This crossover is echoed across the other charity webpages, with much of the online
charity literature containing similarities between methods outlined as potentially 
beneficial treatments for both depression and anxiety in cancer patients, such as: 
herbal medicine, homeopathy, talking therapies, St John’s wort, healing, meditation, 
massage therapy and art therapy (all of which appear in Cancer Research UK’s 
literature pertaining to anxiety and therapy). Royal Marsden also offers similar 
advice, suggesting that cancer patients may benefit from ‘message therapy, 
relaxation, reflexology and aromatherapy’, which the charity suggests can ‘help to 
relieve symptoms and enhance physical and emotion well-being’ for patients 
(www.royalmarsden.org/difference-you-make/helping-cancer-patients-mothers-day).
An additional herbal remedy for anxiety reduction is to drink green tea: ‘a drink made
from the unfermented leaves of the Asian plant Camellia Sinensis’, however, once 
again there is not enough scientific evidence to suggest that consumption may 
prevent cancer. Cancer Research UK, however, does note that ‘there is some 
evidence from early studies to suggest that having green tea might reduce the risk of
some cancers. But at the moment evidence is not strong enough to know this for 
sure’. Beliefs of cancer patients who drink green tea are that it can: ‘boost their 
immune system which might help them fight their cancer’; ‘improve health, energy 
levels and well being’; ‘get rid of toxins in the body’; ‘give them some control over 
their cancer and its treatment’ and that it might ‘treat their cancer if no other 
conventional treatment can’. There has also been suggestions from the media that 





In a similar vein, other herbal remedies are also discussed by Cancer Research UK 
in relation to anxiety and therapy for cancer patients. For example, ginkgo ‘has been 
reported to help people with anxiety, memory loss, stress, sexual problems and 
asthma’. Research has also shown than ginkgo ‘can improve blood flow to the brain, 






Several of the cancer charities explored during this review include information in 
relation to the therapy processes available for cancer patients. For example Royal 
Marsden suggests they have specialist staff who are experts in ‘systemic therapies 
including innovative therapies … [helping patients] to feel well during and beyond 
cancer’ (www.royalmarsden.org/difference-you-make/dr-naureen-starling-speaks-
cancer-treatment). Marie Curie offers more specific advice, suggesting that 
relaxation can be beneficial in helping an individual with a cancer diagnoses to ‘cope 
better with their symptoms and feelings’. Marie Curie’s website offers information on 
‘getting comfortable, relaxing activities, breathing and massage for relaxation [and] 
complementary therapies’. Initial advice from the charity notes ‘aromatherapy and 
reflexology’ as complementary therapies that may be beneficial for relaxation 
(www.mariecurie.org.uk/help/support/being-there/caring/helping-relax). Furthermore, 
Marie Curie suggests that complementary therapies can be beneficial in aiding 
relaxation and should be undertaken in addition to conventional treatments. 
Suggested complementary therapies include aromatherapy, massage, reflexology, 
acupuncture, acupressure, art therapy, hypnotherapy, reiki, relaxation techniques 




Limited online resources were found in relation to therapy and depression and 
therapy and anxiety exclusively. Most resources indicate a consideration of therapy, 
anxiety and depression. However, Macmillan suggests mind-body therapies as a 
method of combating depression. Mind-body therapies are described by the charity 
as ‘based on the belief that what we think and feel can affect our well-being’. 
Macmillan further notes ‘some of the most popular mind-body complementary 
therapies used by people with cancer in the UK’ as being; relaxation, visualisation, 
meditation, hypnotherapy, art therapy and music therapy. The charity notes that such
complementary therapies can be performed at home and in individual or group 
environments 
(www.macmillan.org.uk/information-and-support/coping/complementary-therapies/
complementary-therapies-explained/mind-body-therapies.html).  Macmillan goes into
further detail for the complementary massage therapy, suggesting its benefits in 
being able to ‘relax your mind and body, relieve tension, improve the flow of fluid 
(lymph) in the lymphatic system … [and] enhance your mood’, while also suggesting 
there are various different types of massage and that ‘some studies of people with 
cancer suggest that massage therapy reduced symptoms, such as pain, anxiety, 




Royal Marsden suggests that ‘There are no rules about how a cancer patient will 
feel, or how they should deal with their emotions – the illness affects everyone 
differently’. This, the charity suggests, inspires them to take ‘a holistic view’ in 
offering complementary therapies and occupational therapies. Such treatments 
offered by the charity include ‘a hair-loss specialist, a relaxation service, and the 
therapeutic massage team who provide aromatherapy, massage and reflexology’ 
(www.royalmarsden.org/difference-you-make/complementary-therapies).  
Further information offered by Macmillan as found using the search parameters of 
this review includes discussion of energy-based therapies. Macmillan notes that, 
‘Energy-based therapies aim to improve your physical and emotional health using 
little, if any, physical contact’, however, the use of physical touch may differ for other 
practitioners2. Suggestions for energy-based therapies include; shiatsu, acupressure,
reflexology, therapeutic touch.  
(www.macmillan.org.uk/information-and-support/coping/complementary-therapies/
complementary-therapies-explained/energy-based-therapies.html). Mind-body 
therapies are also explored, as within an earlier section of this review 
(www.macmillan.org.uk/information-and-support/coping/complementary-therapies/
complementary-therapies-explained/mind-body-therapies.html). Psychological and 
self-help therapies are also mentioned by Macmillan, which states such therapies 
can be helpful during or after treatment and may be beneficial in coping with 
‘confusing or upsetting emotions’ 
(www.macmillan.org.uk/information-and-support/coping/complementary-therapies/
complementary-therapies-explained/psychological-self-help-therapies.html). 
However, Macmillan also states that patients don’t always report their use of 
complementary therapies to health care providers and the charity would like to see 
further research done in the area to help in supporting patients and other 
stakeholders in making decisions on the use of complementary therapies. Macmillan 




Depression, anxiety and therapy
Macmillan (www.macmillan.org.uk/information-and-support/coping/complementary-
therapies/types-complementary-therapies) offers a useful directory, listing links to 
information on many of the complementary therapies discussed throughout this 
review. Further information is supplied on talking therapies 
(www.macmillan.org.uk/information-and-support/coping/your-emotions/who-can-
help/talking-therapies.html), with a more detailed explanation of counselling, group 
therapy and CBT being offered. The charity also clarifies information (again, as 
previously discussed at earlier sections within this review) on therapies using herb 
2  For example, it is common for pressure to be applied using 
hands, elbows etc. during therapies such as Reiki. 





This review has explored CAM advice available to cancer patients contained in the 
webpages of the UK’s top five cancer charities, Cancer Research UK, Macmillan 
Cancer Support, Marie Curie Cancer Care, The Royal Marsden Cancer Charity and 
Bloodwise.  
Cancer Research UK and Macmillan placed emphasis on the need to normalize 
terminology in relation to the talking therapies. The charities suggest that this is 
needed to help potential users of the talking therapies in understanding the options 
available to them and to find a good fit in terms of which talking therapy they may 
wish to use. Although the charities recommend talking to GPs, cancer nurses and 
oncologists, this may be a difficult course to pursue, as practioners at the frontline of 
primary care may have limited time to spend with patients. This may require further 
emphasis from cancer charities or organizations such as The Landuu Company, in 
order to have a significant impact on patient understanding of the talking therapies. 
Cancer Research UK and Macmillan suggest that a fuller understanding of patient 
background could be beneficial in determining which CAM (if any) would be 
appropriate. For example, people with spiritual inclinations may wish to become 
involved with CAM involving spiritual components, however, this would not be the 
appropriate route for other patients. There is also consideration of those people who 
feature significantly in the ongoing care of the patient from Macmillan, such as family
and friends who may be acting, informally or formally, in the capacity as carers. This 
is an interesting contrast to the materials provided by the other charities discussed 
within this review, which primarily lend focus to cancer patients themselves. This 
suggests that it may be beneficial to involve individuals who know or are caring for 
someone with cancer in CAM provision as it may help them to better cope 
emotionally with the situation and also bridge supporting strategies across the CAM 
provider and the home setting, in which most of the care takes place.  
The review shows that there is a strong cross-over between the charities’ results 
pertaining to depression and anxiety, with the charities reviewed offering advice on 
the same CAM for patients with depression or anxiety.  On the other hand, The 
Royal Marsden Cancer Charity, for example, places emphasis on the benefits of 
CAM that they themselves offer to patients.  Each of the five charities reviewed 
offered no direct information with reference to emotional well-being or emotional 
resilience. The lack of primary information for the improvement of emotional well-
being seems to suggest that the charities  do not consider it as a distinct area for 
advice, while depression and anxiety, possibly because they are recognised medical 
conditions, receive comprehensive coverage with emotional well-being occuring as 
an additional benefit. 
It is also key to note that Cancer Research UK and Macmillan do not advocate for 
the use of CAM to the exclusion of tradtional methods of cancer treatment. The 
information provided suggests that the two charities are simply attempting to inform 
potential users of these therapies. Conversely, while accepting that it is a challenge, 
both Cancer Research UK and Macmillan do advocate the use of formal research 
methods to investigate the effects of CAM for people who have cancer.  The 
following section discusses research findings on just this subject.
Empirical Research Review
The Landuu Company commissioned a literature review of the effects of CAM in the 
facilitation of improved emotional well-being, depressive or anxiety symptoms in 
individuals living with chronic illness, in particular cancer. The expicit objective is to 
have an evidence base to refer to in consultation with clients and also to plan for 
future development of their service model.
Method
Relevant studies were identified via a systematic search of four databases 
(Academic Search Ultimate, CINAHL, MEDLINE Complete, PsychARTICLES) using 
a scoping search strategy that included base keywords and their synonyms as 
suggested by the database's internal thesaurus (see Appendix 1).  
Search results were included for title and abstract review according to the following 
inclusion criteria: peer reviewed articles; written in the English language; published 
within the last 15 years; samples of male and female adults only.
After automated removal of duplicates, the search yielded 60 studies for title and 
abstract sifting for eligibility for inclusion (see Appendix 2 for inclusion criteria and 
sifting protocol). Forty-four studies were excluded as not relevant, leaving 16 studies 
for full text review. One study was excluded during the full text review process. A 
citation search during full text review of the remaining 15 articles produced a further 
26 articles for potential inclusion that yielded an additional 5 articles eligible for 
inclusion in the review (see Figure 1 for flow chart of abstract sifting and full text 
review process).  
Of those studies that did not meet the criteria for inclusion, 31 studies were excluded
on the bases of pertaining to cost-benefit studies of CAM, focussing upon samples of
children, dissertations (i.e. not peer reviewed), studies that evaluated only 
pharmacological interventions or did not include a measure of emotional well-being / 
depressive or anxiety symptoms. Seven studies were excluded as they used CAM 
therapies in an illness other than cancer; five studies were methodological / 
theoretical articles concerning the basis of CAM therapies; 11 articles were review 
articles; four studies did not include post intervention measures to be able to 
evaluate improvement.
Design and Demographic Information
Twenty studies were included in the review, encompassing CAM therapies used as 
interventions to promote feelings of emotional well-being, or reduce symptoms of 
depression or anxiety in cancer patients. Half the studies followed a randomized 
controlled 
Figure 1.  Flow chart of abstract and full-text review process
trial (RCT) design, with an additional two using RCT-Pilot design. Two studies were 
a quasi-experimental design, two used a pre-post intervention approach and two 
used a self-selecting design. One study explored the feasibility of their CAM therapy 
and one study used an evaluation design.  
Methods of randomisation varied across studies; levels of reporting randomisation 
also varied with minimal reporting in the presence of randomisation finishing at the 
method of randomisation.  CONSORT guidelines require naming the role of the 
person who conducted the randomisation and the how the sequence was concealed.
Sixty percent described randomisation in their methods section, however only 80% 
of those detailed the method, 50% the method of concealment and 30% listed the 
person responsible.
Blinding is also required by the CONSORT statement in RCT studies.  Seven studies
reported blinding processes, which was always associated with randomised 
methods.  All of the seven studies detailed who was blinded within the study.  Only 
Loh, Lee and Murray (2014) reported blinding of participants - a process made 
easier as the two groups were separated geographically.  Most studies found that 
the active nature of the controlled trials meant that participants realised that the form 
of intervention related to the measures was the study.  Even so, only three of the 
seven studies listing blinding procedures talked about methods they took to limit 
possible bias from participant knowledge of study research aims.
Eight studies were conducted in the United States, with two studies each from 
Canada, China, Denmark, Malaysia and one study each from Australia, Israel, New 
Zealand and Spain. Sample size ranged from 29 - 272 with a median of 156 
participants at recruitment point into a study, with a range of 48.22% - 100% (median
= 89.37%) of participants' data being included for analysis. Studies were included 
from 2004 onwards.  The search was conducted in July 2019.  Studies published 
before or after these dates are not included.
The majority of the studies (13) considered two or more of emotional well-being, 
depression or anxiety concurrently as a focus for their investigation, with only 7 
papers considering one of the outcome variables. Group characteristics were tested 
for equivalence using t-tests or chi-square methods. AN(C)OVA was the most 
popular statistical method used for analysis of the primary outcome variables. 
Although four papers stipulated linear regression and three papers explicitly referred 
to mixed-effects modelling, no results referred to rates of change in the outcome 
measure that would represent slope terms, or random effects within the model 
structures. Consequently, it is assumed that the results represent aggregated Group 
values as a between-subjects variable and Time as a within-subjects variable.
Cancer is a very broad term that covers a multitude of divergent diagnoses.  
However, most studies constrained their research focus to one cancer type.  Half of 
the studies suitable for inclusion considered patients with breast cancer; three 
studies explored the effects of CAM for individuals with prostate cancer; one further 
study considered breast and prostate cancer as separate conditions. Four studies 
included participants with a heterogeneous mix of cancers.  Lung cancer and 
lymphoma were the focus of the final two papers.  
This was not the case, however, with cancer progression, with many studies 
choosing to include a range of disease stages.  Only three studies included stage 0 
participants within their sample and only five studies included people with stage IV 
cancer.  As such, the majority of studies included stage I - III cancer patients.  At 
randomisation, however, this covariate was largely controlled for, consequently 
effects by stage of disease are not detectable.  Similarly, studies also ran their trials 
with samples that were at different stages of their traditional cancer treatment plans. 
Only one study included patients who had yet to begin their cancer treatment, 
however, and one study specifically looked at any effects of CAM between groups at 
pre- and post-treatment stages.  Five studies worked solely with patients undergoing 
treatment; six studies worked solely with patients who had completed their treatment.
Six studies included in their sample patients who were either undergoing or finished 
with traditional treatment.  
Overview of Individual Study Quality
The quality of each study was assessed using the CONSORT Statement for 
Randomized Trials of Nonpharmacologic Treatments (NPT) Checklist (Boutron, 
Altman, Moher, Schulz & Ravaud, 2017). The original CONSORT statement 
extension for NPTs was published in 2008 and updated in 2010. The checklist 
comprises 25 categories, containing sub-categories. The date range of this literature 
review encompasses articles published before the CONSORT Statement for NPTs 
was established, consequently adjudication against these standards for those 
articles may be unfair.  Ratings against the CONSORT NPT checklist were 
conducted for each article, however, to explore whether more articles fulfilled the 
standards as a function of time passing, with an expected increase in reported 
details in the most recent articles. Median percentage for included items across the 
studies was 69%; range for this sample of studies was 35% - 82%, however, if only 
inspecting studies that purported to use the RCT design, range was 42% - 82%, with
the lower range study occurring in 2006.  Studies published more recently are likely 
to have a higher percentage of CONSORT items included in their full text. Full data 
for the quality checklists data can be found in Appendix 3.
Fifty percent of studies detailed a power analysis process to be able to detect a 
defined point change in primary outcomes measures, predominantly based upon 
findings in previous research. Every power analysis accounted for attrition rates over
the course of the study. Median rate for completion of the study protocol over the 
studies was 50% with a range of 12.96% - 100% (this figure includes unplanned 
subgroup analyses that were then claimed as findings within the discussion). The 
percentage of each sample size included in the final data analysis was calculated 
(see Table 1).  Results within this review will not be synthesised by meta-analysis, 
however, the fact that power analyses within the studies estimated much lower rates 
of attrition (~25%) means that drawing conclusions from the results must be done 
with caution.
Each study used validated and reliable assessments for their outcome measures of 
improvements in emotional well-being, depression and / or anxiety (see Appendix 4 
for a list of outcome measures used across studies). These assessments took the 
form of Likert scales. Many studies included the reliability values of the tasks, 
however, none of the studies documented recommended test-retest interim periods. 
Although parametric analysis has been shown to be robust with Likert scale data, no 
studies documented their inspection of the data for normality before choosing to run 
parametric analyses. Additionally, and of critical importance where relevant, 
clustering of participants to take account of their groupings did not occur in any study
where multi-groups or multi-sites ran the study protocol. Failing to account for nested
structures within data in this way has been demonstrated to produce anti-
conservative results. This may introduce bias into a study's final results so statistical 
significance / effect sizes need to be interpreted with caution.
Results
In this sample, it is true to say that the forms of intervention here are complementary 
rather than alternative, as all studies worked with samples of patients that were pre-, 
during- or post their traditional treatment plan.  Twelve of the studies represent an 
integrative health approach to cancer treatment as the study was run within or 
alongside an operational cancer treatment centre or oncology unit within a hospital 
(Adamsen et al., 2009; Bar-Sela, Danos, Visel, Mashiach & Mitnik, 2015; Beard et al.
2010; Chen et al., 2013; Cohen, Warneke, Fouladi, Rodriguez & Chaoul-Reich, 
2004; Courneya et al., 2007; Isa, Moy, Abdul Razack, Zainuddin & Zainal, 2013; Loh 
et al., 2014; Moadel et al., 2007; Oh et al.,  2009; Paras-Bravo et al., 2017; Quist et 
al., 2012; Schneider, Hsieh, Sprod, Carter & Hayward, 2007; Witek-Janusek et al., 
2008).  Every study documented the secondary effects of cancer on an individual's 
quality of life, arising from not only the disease's physiological assault on the body 
but also from the traditional treatments administered to slow tumour growth.  
Manifestations of secondary effects are multiple; the majority of studies cited muscle 
weakness, due to excess fatigue and a consequent reduced motivation to maintain 
normal levels of activity, an increase in depressive symptoms or anxiety symptoms 
over loss of control and fear about tumour growth or recurrence. All studies were 
clear in their aims to relieve all or some of these secondary effects through the use 
of their intervention.
Four studies used a single arm design with no control condition (Bar-Sela et al., 
2015; Paras-Bravo et al., 2017; Quist et al.,  2012; Schneider et al., 2007).  There 
was only one study, Liu et al., (2017), that used an active control condition as the 
sole contrast to the intervention; Loh et al., (2014) and Gudenkauf et al., (2015) 
included both an active and passive control group.  The rest of the studies included 
passive control groups in the form of either standard care, wait list or education 
sessions.  No study included data from a group of healthy participants as a form of 
control.
The majority of studies used an intervention built upon a base of physical exercise 
and measured its effects on the outcome variables: emotional well-being, depression
or anxiety. Within the sample, interventions ranged from resistance and aerobic 
exercise at differing levels of intensity (Adamsen et al., 2009; Courneya et al., 2007; 
Quist et al.,  2012; Schneider et al., 2007) to Qigong or Yoga (Chen et al., 2013; 
Cohen et al., 2004; Culos-Reed et al., 2006; Liu et al., 2017; Loh et al., 2014; 
Moadel et al., 2007; Oh et al.,  2009) to muscle relaxation (Isa et al., 2013; Paras-
Bravo et al., 2017) and finally relaxation mixed with mindfullness stress management
training programs (Beard et al. 2010; Cameron et al., 2007; Gudenkauf et al., 2015; 
Nidich et al., 2007; Penedo et al., 2006; Witek-Janusek et al., 2008). Bar-Sela et al., 
(2015) examined multiple intervention methods in a retrospective analysis of sample 
data.  None of the included studies examined the method of emotion-freedom 
technique, human software engineeering, neurolinguistic programming or energy 
alighment methods (although one study did use Reiki as a contrat to their primary 
intervention using relaxation).  
It seems useful to use these groupings as a way to explore the study results and 
possibly tease out any differential effects that may occur according to types of 
intervention.  Accordingly, sections below will cover these levels of intervention with 
an initial evaluation of Bar-Sela et al., (2015) whose study represents a super-
ordinate exploration of CAM as a method for improving patient outcomes within one 
supportive care setting, rather than focussing upon discrete CAM methods. 
Study outcomes are listed under these headings in Table 1.  Given the time 
constraints of the review process, effects sizes (Cohen’s d) were calculated and 
reported for articles that included the necessary data to be able to do so. Otherwise, 
p. values are used as a proxy for findings of interest. Interpretation guidance for 
Cohen's d is that a value of 0-0.1 indicates no effect, 0.2-0.4 represents a small 
effect, 0.5-0.7 indicates an medium effect size and values of 0.8 and above 
indicating a large effect size.  Effect sizes that include a minus sign indicate that 
participants responses makes it appear their symptoms have worsened with the 
intervention, although the size of the value still needs to be interpreted.
Multiiple Complementary Therapies within a Cancer Care Centre
Bar-Sela et al., (2015) conducted a retrospective analysis of individuals covering 
multiple cancer diagnoses across multiple types of complementary therapies.  The 
sample of the study self-referred to the CAM service and then selected a therapy of 
their choosing over a period of two years.  As such there is no comparison of sample
characteristics, simply a global analysis of the measures of emotional well-being, 
depression and anxiety captured at baseline, end of therapy and a six-week follow-
up period. Improvements across all outcomes were evident from baseline to twelve-
weeks.
Exercise interventions
Four studies used exercise as their intervention to explore effects across the three 
outcomes of interest, two of which used an RCT design (Adamsen et al., 2009; 
Courneya et al., 2007).  Schneider et al., (2007) used the pre/post intervention 
design and Quist et al., (2012) reported their design as a pilot study.  Courneya et 
al., (2007) found no difference between standard care participants or exercise 
protocols, using a three arm RCT design for all outcomes.  Although not explicitly 
stated, the exercises used suggested that a gym setting was used for resistance and
cardio exercise methods of exercise across all studies. Schneider et al., (2007) 
focussed upon emotional well-being and depressive symptoms and analysed 
participants as a function of their treatment status - whether they were during or post 
traditional treatment protocol, however no associations between exercises and 
outcomes were demonstrated.  Adamsen et al., (2009) reported small effects for low 
and high intensity exercise across multiple diagnoses of cancer in their study. The 
experimental groups improved to a greater extent than the standard care control 
group in subscale measures of emotional well-being across two assessment tests.   
Study Characteristics by Intervention
Page 
Intervention Design Control Diagnosis Stage Status Gender Analysis Measures Outcome Variables Effect size
Exercise
RCT Standard Breast I; II; III D F 49.2 Mixed-model FACT-A E R; A; S; T >.05 none
CES-D D R; S; T >.05 0.01 none
A; S; T >.05 0 none
STAI A R; S; T >.05 0.078 none
A; S; T >.05 0.096 none
Pre/Post None D; P unclear ANCOVA QoLIC-V3 E D; T .378 none
P; T .096 none
T -0.075 none
BDI D D; T .001
P; T 0 none
T -0.175 none
RCT Standard Multiple D F; M 47 Regression EORTC E G 0.3 small 
MOS SF-36 G 0.32 small
Pilot None Lung III; IV Pr; P F; M 63 T-Test FACT-L E T .025 0.38 small
Yoga
RCT Wait-list Lymphoma D; P F; M 51 CES-D D G*T >.05 none
G; T .56 -0.131 none
STAI A G; T .9 0.279 none
Pilot Wait-list Breast P F; M 50 ANOVA EORTC E G; T <.05 0.877 large
POMS D G; T <.01 0.62 medium
RCT Standard Breast I; II; III D; P F 54.81 Regression FACT-G E G 0.9 -0.07 none
POMS A G 0.3517 small
P FACT-G E G <.015 -0.616
POMS A G <.046 0.503 medium
Feasibility Standard Breast I; II P F 54.5 75     (88) ANOVA QoLIC-V3 E G .001 0.894 large
G*T .009 0.563 medium
Qigong
RCT Standard Multiple D; P F; M 60 Regression FACT-G E G <.001 medium
POMS D G .029 0.426 small
A G 0 0.431 small
RCT Wait-list Breast D F 50 FACT-G E G*T >.05 0.246 small
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Qigong RCT Breast I; II P F ANCOVA FACT-B E G >.05 0.546 medium
DASS-21 D G .49 none
A G .8 none
RCT Stretching Breast D; P F 51.1 Mixed-model FACT-B E G; T <.001
HADS D G; T >.05 none
HADS A G; T >.05 none
PMR
Quasi-E Prostate M 72.3 ANOVA DASS-21 D G*T .096 0.009 none
A G*T < .001 0.995 large
Pre/Post None Multiple D; P F; M 52.64 FACT-G E T <.001 2.438 large
Relaxation
RCT* Half-day Prostate I; II P M 65.1 SEM MCS E G <.01 0.485 small
FACT-G G <.05 0.304 small
Breast Pr F 52.15 ANOVA FACT-G E G; T >.05 0.129 none
STAI-s A G; T >.05 0.217 none
RCT-P Prostate D M 64.3 ANOVA FACT-G E G >.05 none
CES-D D G >.05 none
CES-D D G .05
STAI A G 0 none
RCT Education Breast P F 54.28 ANOVA FACT-B E G*T 0.332 small
ABS D G*T .005 0.448 small
Meditation
RCT Standard Breast II; III; IV P F 63.85 ANCOVA FACT-B E G .046 0.253 small


















































































Note:  PMR = Progressive Muscle Relaxation; RCT = Randomised Controlled Design; Quasi-E = Quasi-Experimental; Pr = Pre- treatment; D = During treatment; P = Post treatment; F = Female; M = Male; N = 
Sample size; For explanations of measures, please see appendix 4; Outcomes: A = Anxiety; D = Depression; E = Emotional well-being; Variables:  A = aerobic training; D = During treatment; G = group; P = Post 
treatment; R = resistance training; S = standard care; T = time; 
In a later study, Quist et al., (2012) demonstrated small effects for an exercise 
intervention for lung cancer patients, particularly relevant for such a sample, 
considering that exercise impacts directly upon lung use.  Their explicit aim was to 
test safety limits for such a protocol. As a pilot study, change is measured from 
baseline only with no control group against which to compare relative efficacy.
Yoga
Four studies used Yoga as an intervention.  Cohen et al., (2004) found no effects of 
this intervention on depressive or anxiety symptoms using an RCT design.  
However, Culos-Reed et al., (2006) found medium effects of Yoga for depressive 
symptoms and large effects of Yoga upon emotional well-being.  The contradictory 
findings across these studies may be due to design introducing bias into the results:  
Culos-Reed et al., (2006), although formally nominating their study a pilot, used 
random assignment to experimental or wait-list condition in waves. This clustering 
was not included in the analysis.  Additionally, where Cohen et al., (2004) used a 
mixed model regression approach in their analysis, Culos-Reed et al., (2006) used 
ANOVA.  The difference between these two methods and how they are able to use 
the variance within the data may be a source of the apparent contradictions.  The 
small group sample size for each wave in Culos-Reed et al., (2006) (n = 10) and 
small group sample size for both studies suggests that these results need to be read 
with skepticism. Witek-Janusek et al., (2008) had twice the sample size of Culos-
Reed et al., (2006) and also found large main effects for emotional well-being and 
medium interaction effects for emotional well-being for group over time.  Witek-
Janusek et al., 2008, however, used a feasibility design and participants were able to
choose how they participated in the study, which may introduce a source of bias into 
the results and hence the difference in magnitude of these results.  
Yoga exercise featured as part of a mindfulness based stress reduction (MBSR) 
program which utilises breath awareness, meditation while sitting and walking and 
'mindful yoga'.  The study, by Moadel et al., (2007), also used an RCT design and a 
bigger sample size of individuals who were either finished with or undergoing 
chemotherapy. Unfortunately, the power imbued in a large sampel size at 
recruitment stage was confounded by the fact that 75% of the intervention group did 
not take part in any of the intervention sessions. They found no effects of Yoga upon 
emotional well-being within the global sample.  They did, however, conduct a sub-
group analyses of participants who had completed their chemotherapy and detected 
a medium effect of Yoga upon anxiety measures. Interestingly, the emotional well-
being analysis in this sub-group registers as worse. The researchers attribute this 
result to decrements in scores among the control group, as well as improvements for
the Yoga group but do not include sufficient detail to be able to confirm this.
Qigong
All studies examining the effects of Qigong used an RCT design.  The earliest study 
of the four included in this sample is Oh et al.,  (2009).  They reported missing data 
within outcome measures but not the absolute level, nor their methods for imputation
of values, nor their analysis of data with and without imputed values. The study 
reports a medium effect of Qigong for participants' emotional well-being and small, 
postive effect sizes for depression and anxiety between Qigong and standard control
conditions. Chen et al., (2013) also reported small effects for emotional well-being 
and depressive symptom outcomes.  Both studies used passive control conditions.  
Loh et al., (2014) contrasted the effects of Qigong with both standard care and an 
exercise group.  Exercise was operationalised as a line-dancing group. While they 
demonstrated a medium effect for emotional well-being, their study design found no 
difference between conditions for depression and anxiety.  Liu et al., (2017) 
completed a similar study design with 'stretching' as a control condition for Qigong 
with an explanation that stretching alone does not encompass the breathing and 
thoughtfulness that accompanies movement within Qigong practice.  Although they 
reported a significant effect for emotional well-being for group, no statistic was listed 
for calculation of Cohen's d.  Liu et al., (2017) demonstrated no difference for 
symptoms of depression or anxiety across Qigong and the stretching group, across 
the entire sample and across a subgroup analyses of participants who practised 
extensively at home.
Progressive Muscle Relaxation (PMR)
Emotional well-being, depression and anxiety outcomes are covered across two 
studies: Isa et al., (2013) and Paras-Bravo et al., (2017).  PMR as used by Isa et al., 
(2013) involved training for abdominal breathing and progressive relaxation through 
tensing and releasing the 16 large muscle groups of the body over a period of 15 
seconds for each muscle group.  Paras-Bravo et al., (2017) trained their participants 
in an abbreviated form of PMR that maintained normal breathing throughout the 
progressive relaxation stage of the protocol.  Isa et al., (2013) enrolled participants in
home practice for six months; Paras-Bravo et al., (2017) enrolled participants for four
weeks.  Neither study used an RCT design, and the quasi-experimental design of Isa
et al., (2013) had complete separation of participants by exercise condition (PMR 
versus Information group), also by site - all of the information group participants were
from a separate, independent hospital, introducing confounds into the data analysis. 
Paras-Bravo et al., (2017) recruited their sample across 10 hospitals and completed 
the training within the hospitals' oncology units. Isa et al., (2013) reports a large 
effect for an improvement in anxiety symptoms but no effect for depressive 
symptoms. This study did not include emotional well-being as an outcome. Paras-
Bravo et al., (2017) found a large effect for improvement in emotional well-being over
this single arm, single outcome measure study.
Relaxation
Four studies concentrated on relaxation as an intervention to improve emotional 
well-being, depression or anxiety symptoms.  Two studies, Penedo et al., (2006) and
Gudenkauf et al., (2015), using an RCT design, found small effects for emotional 
well-being and  emotional well-being and depression respectively.  Both of these 
studies used participants who were post traditional treatment.  Cameron et al., 
(2007) and Beard et al., (2010)'s participants were either pre- or during treatment 
while the study was carried out.  Both of these studies report no difference between 
standard care control groups and relaxation group.  Beard et al., (2010) conducted 
subgroup analyses using data from participants who registered as clinically 
depressed (n = 7) or clinically anxious (n = 10) across the groups at baseline 
assessment. The null finding for anxiety remained.  They report a p. value of .05 
finding for depression, however there are no average values within the article by 
which to calculate effect sizes.  Given the borderline significance value and the small
sample size, plus the use of ANOVA for analysis, this result needs to be interpreted 
with caution.
Meditation
One study examined meditation's effect on emotional well-being through an RCT 
design, Nidich et al., (2007).  After completing training in the method, participants 
were expected to practice at home twice daily.  Self-report was used to monitor 
participant adherence to the program and results represent difference between 
basline and end of study assessment, two years later (assessments were conducted 
at 6 month intervals).  Emotional well-being improved over time more for the 
meditation group, however the significance of the effect is borderline (p. = .046) and 
the duration of time between measures compared with the scale of the assessment 
period (two years between values with a construct that asks individuals to evaluate 
their life over the last seven days) introduces a note of caution when interpreting the 
results.
Discussion
This review aimed to investigate effects of complementary interventions for 
individuals with a concurrent diagnosis of cancer on emotional well-being, 
depression and / anxiety. In total, 20 studies were reviewed across six 
complementary medicine methods.  The majority of studies used an RCT design or 
purported to be at the beginning of confirmatory stages of testing methods by 
running feasibility or pilot studies.    
Most studies chose to focus on two or more of the three outcomes which may 
suggest that although some of the chosen interventions hail from ancient medical 
customs, the research into their active ingredient is relatively new and researchers 
are still exploring the range of effects an intervention may influence.  All studies 
reporting large effects for any outcome were a) not of RCT design and b) ran 
protocols that could introduce bias into the data analysis and inflate p.values, such 
as small sample sizes, self-selection to study arm.  
Very few studies grounded their choice of intervention in any theory, however some 
studies reported the focus on breathing as key to increasing flow of oxygen to the 
muscles that helped metabolise toxins while the mind calmed with deeper breathing; 
believed effects arose from the ability of the connected mind and body to promote 
regulation of the body somatic system through increased oxygenation and calming.  
As well as using psychosocial measures of improvement, five studies included 
objective measures of physiological functioning such as peak oxygen levels, walking 
capacity and grip strength (Adamsen et al., 2009; Courneya et al., 2007; Culos-Reed
et al., 2006; Quist et al., 2012; Schneider et al., 2007). Three studies (Chen et al., 
2013; Liu et al., 2017; Witek-Janusek et al., 2008) included blood measures such as 
cortisol levels or immunological functioning. Those results are not reported here as 
they are out of the scope of the review, however, it is encouraging to see research 
projects planning for converging patterns of evidence across different levels of 
analysis and should be explored further as a method for limiting bias when blinding 
to conditions is not possible and self-report measures are the predominant method 
for collecting the psychosocial outcomes.  
The choice of control status was, in the main, passive, with only three studies 
choosing active controls to begin to untangle the mechanism for effects within 
interventions where present (Courneya et al., 2007; Liu et al., 2017; Loh et al., 
2014). Only one study listed a group of healthy controls, however they did not collect
primary outcomes, nor report them in their article.  Healthy participants who engage 
in the interventions and control groups, either as discrete groups or mixed with 
participants, describe another kind of baseline that may inform future planning and 
study design.  Having healthy controls within the same groups could also inform 
blinding protocols for practitioners.
  
Implications for future research potential
Effects of the interventions within this sample of papers, looked at conservatively, 
are small to negligible.  Perhaps the strongest implication that can be derived is that 
detection of the small effects within the sample arose from RCT designs as opposed 
to other study designs.  If we accept that RCT is the best method to capture effects 
then future research using this design is needed to replicate and extend these 
results.  Since most studies concentrated on one or two cancer diagnoses, it may be 
the case that certain interventions work better for certain cancers, for example, the 
feasibility of the exercise program for participants with lung cancer yielded small 
effects sizes for emotional well-being, while the physical exercises for a study with 
breast and prostate cancer (Schneider et al., 2007) yielded none. This has 
implications for how cancer care centres are organised (whether specialist centres or
general cancer treatment centres) and how researchers collaborate to facilitate 
sufficient participants within diagnoses for such comparisons.
Also, power to detect effect sizes may have been compromised by high rates of 
attrition.  Where attrition was analysed, younger participants were more likely to drop
out but transport difficulties was also cited as a reason for withdrawal.  While a study 
can plan to include more participants to ensure sufficient power, an investigation into
why age and transport issues are a common reason for attrition across studies may 
be useful.  It could be that inequalities are occurring.  It is well known that, additional 
to health, psychological and social decrements in functioning, there is a financial cost
for families with members who have cancer. If this indirectly influences access to 
work or transport, then results of studies may be indirectly biased.  A similar concern 
exists for the location of studies. Anonymity conditions set by journals may have 
meant that papers could not detail the sites of their studies, however if studies are 
always within urbanised provision, another bias may be present due to the under-
representation of participants from rural locations.
The group setting was pervasive among these studies, with trial sessions 
predominantly occuring in groups and individuals practising alone at home.  Where 
standard care or wait-list condition was used for the control condition, this raises the 
question of the influence of social support on any effect that is detected.  Given that 
a description often used for people with a cancer diagnosis is a ‘feeling of isolation’, 
then the group setting could be a source for improved feelings of welll-being, 
depression or anxiety.  Future research could take account of this, either through 
design or as the central research question.
The group factor was often cited as problematic for blinding protocols that involved 
participants.   If blinding is not possible for practitioners and participants, co-design 
could be an implication for future research.  Involving primary stakeholders in the 
construction of a trial protocol could also improve adherence rates and improve 
confidence in results.  Replication of trials is also needed to build confidence in small
effects.  Building networks amongst practitioners, to run many small (but well-
constructed, sufficiently powered) studies could facilitate strength through the use of 
the same protocols, measurement instruments and analysis plans. The Many-Lab 
approach in psychology has worked well in networking disparate research 
laboratories within a collaborative approah where each collect a small number of 
observations using shared protocols and materials.
    
Limitations
This study has several limitations.  Firstly, the terms for the literature search, while 
comprehensive in their use of synonyms and beginning from an agreed base, may 
have produced limited results.  Once articles were collated, it became clear that 
emotional well-being was nested inside the construct of 'Quality of Life', for which 
there are many formal assessment instruments.  Articles that included a quality of life
measure as a primary outcome often referred to the construct in the article title or 
abstract, referring to instrument subscales further down the article, so it is highly 
likely that there are many more studies that document emotional well-being 
outcomes if a wider search is conducted that includes ‘quality of life’ as a search 
term, or the formal assessment tasks in the search criteria.
Also, a citation search was conducted within the 16 articles that were eligible for 
inclusion from the initial database search results, however, due to time constraints, 
the citation search was not extended to those further articles considered eligible. 
Consequently, this sample represents a truncated selection of papers, so results 
should be taken as tentative.
Time constraints also truncated the search to the EBSCOhost database. This was a 
conscious decision made by the author once the first database results were 
exported.  Extending the search to EMBASE database is in itself not a time 
consuming task, however, sifting and reviewing de-duplicated results would have 
been beyond the resources committed to this strand of the project.
Several of the complementary medicines listed in the search terms yielded null 
results. Given the limitations of the search listed above, it may be useful to conduct a
second search before regarding this as conclusive evidence for a gap within the 
research literature.  In the absence of peer reviewed articles for those interventions, 
the above studies could suggest templates of robust protocols to follow in generating
such research.
Conclusions
The findings from this review point to possible small effects of particular 
complementary interventions for emotional well-being, depressive symptoms and / or
anxiety symptoms within quite narrow groups of cancer diagnoses.  The practices of 
Yoga, Qigong and Relaxation all appear to be able to motivate a small, reproducible 
level of effect in the experimental conditions.  The most robust method for the 
detection of these effects appears to be the randomised controlled design, and 
quality checks using the CONSORT Statement for NPTs point to several areas 
where design can be made more rigorous, such as blinding and accounting for 
clustering / correlated data samples through choice of statistical analysis method.  
Recommendations for extending the utility of RCT design with the hope of improving 
study adherence, completion and increasing sample diversity are made.  Building 
studies that are generalisable to wider populations may facilitate greater discussion 
round integrating traditional and complementary medicines in the longer term.
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Appendices
Appendix 1 - Search Terms and String
Three strings were constructed for initial search and then combined. Filters were 
then applied and duplicates removed before exporting to management sofware for 
title and abstract review.
Search String 1
(DE “emotional intelligence” OR “emotional well-being” OR “Emotional well being” 
OR “Emotional well-being” OR)
AND
(DE “oncology” OR DE “Neoplasms” OR “Integrative oncology” OR “Cancer 
treatment”)
AND
(DE “alternative medicine” OR “Alternative therapies” OR “Complementary medicine”
OR “Complementary therapies” OR “Holistic medicine” OR “Holistic therapies” OR 
“Integrative medicine” OR “Integrative therapies” OR “Mind-body practices” OR 
“Mind body practices” OR “Mind-body techniques” OR “Mind body techniques” OR 
“Mind-body therapies” OR “Mind body therapies” OR “Emotional release” OR 
“Emotional intervention” OR “Neuro-linguistic programming” OR “Neuro linguistic 
programming” OR “Qigong” OR “Emotional freedom techniques” OR “Relaxation” 





(DE “oncology” OR DE “Neoplasms” OR “Integrative oncology” OR “Cancer 
treatment”)
AND
(DE “alternative medicine” OR “Alternative therapies” OR “Complementary medicine”
OR “Complementary therapies” OR “Holistic medicine” OR “Holistic therapies” OR 
“Integrative medicine” OR “Integrative therapies” OR “Mind-body practices” OR 
“Mind body practices” OR “Mind-body techniques” OR “Mind body techniques” OR 
“Mind-body therapies” OR “Mind body therapies” OR “Emotional release” OR 
“Emotional intervention” OR “Neuro-linguistic programming” OR “Neuro linguistic 
programming” OR “Qigong” OR “Emotional freedom techniques” OR “Relaxation” 





(DE “oncology” OR DE “Neoplasms” OR “Integrative oncology” OR “Cancer 
treatment”)
AND
(DE “alternative medicine” OR “Alternative therapies” OR “Complementary medicine”
OR “Complementary therapies” OR “Holistic medicine” OR “Holistic therapies” OR 
“Integrative medicine” OR “Integrative therapies” OR “Mind-body practices” OR 
“Mind body practices” OR “Mind-body techniques” OR “Mind body techniques” OR 
“Mind-body therapies” OR “Mind body therapies” OR “Emotional release” OR 
“Emotional intervention” OR “Neuro-linguistic programming” OR “Neuro linguistic 
programming” OR “Qigong” OR “Emotional freedom techniques” OR “Relaxation” 
OR “Meditation” OR “Human Software Engineering” OR “Energy Alignment 
methods”)
Appendix 2: EWB Title and Abstract Sift Criteria
EWB Sift Criteria:  Effectiveness of interventions
The aim of this literature review is to assess the impact of complementary / alternative
medical treatments on a patient’s emotional resilience and wellbeing, and possible link to
better response to cancer treatments.
For all titles and abstracts answer ALL questions unless coded as Rev or Exclude at Q1
Or excluded at any stage
QUESTION ANS QUALIFIER ACTION
Q1 Is this an 
evaluation of an 
intervention or 
programme
No Review / Systematic Review or 
Meta-Analysis
Code as Rev
Evaluation of cost-benefits Exclude
Other Exclude
Yes Population - if focuses solely on 
children
Exclude
Illness is other than cancer Go to Q4
Document type - dissertation Exclude
Intervention - if focuses solely on
pharmacological treatment
Exclude
Intervention - if complementary / 
alternative methods mentioned
Go to Q2
Intervention population, illness, 
doc type unclear
Go to Q2
Q2 Does the study 
measure well-
being / emotional 
resilience 
outcomes




being / emotional 
resilience
No Exclude
Yes Reduce / improve scores on 












Use qualitative methods of 
measuring an increase in well-
being / emotional resilience
Code as 
Review 4 (R4)




Q3 Does the study 
have at least one 





EWB Sift Criteria:  Effectiveness of interventions for diseases other than
Cancer - Q4
The ultimate aim of Q4 is to assess the impact of complementary / alternative medical
treatments on a patient’s emotional resilience and wellbeing, and possible link to better
response for treatments other than cancer.
For all titles and abstracts answer ALL questions unless excluded at any stage
QUESTION ANS QUALIFIER ACTION








disease / long 
term chronic 
condition
No Review / Systematic review or 
meta-analysis
Code as Rev
Evaluation of cost-benefits Code as Econ
Other Exclude
Yes Document type - dissertation Exclude
Intervention - if focuses solely on
pharmacological treatment
Exclude
Intervention - if complementary / 
alternative methods mentioned
Go to Q4.2
Unclear Code as 
Unclear & go to 
Q4.2
4.2 Does the study 
measure well-




Yes Reduce / improve scores on 
measures of well-being / 
emotional resilience
Code as Alt1 & 
go to Q4.3
Reduce / Improve the scores on 
measures of depression
Code as Alt2 & 
go to Q4.3
Reduce / Improve the scores on 
measures of anxiety
Code as Alt3 & 
go to Q4.3
Use qualitative methods of 
measuring an increase in well-
being / emotional resilience
Code as Alt4 & 
go to Q4.3
Other well-being / emotional 
resilience outcome
Code as Alt5 & 
go to Q4.3
4.3 Does the study 




Yes Include for 
appendix list
Unclear Exclude
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Cohen 2004 RCT 58.82
Culos-Reed 2006 Pilot RCT 29.41
Penedo 2006 RCT 58.82
Cameron 2007 Quasi-Experimental
Courneya 2007 RCT 47.06
Moadel 2007 RCT 47.06
Schneider 2007 Pre-post Intervention
Witek-Janusek 2008 Non-randomised
Adamsen 2009 RCT 64.71
Nidich 2009 RCT 82.35
Beard 2010 Pilot RCT 35.29
Quist 2012 Feasibility Pilot
Chen 2013 RCT 52.94
Isa 2013 Quasi-Experimental
Loh 2014 RCT 47.06
Bar-Sela 2015 Phase-II Study
Gudenkauf 2015 RCT 52.94
Paras-Bravo 2017 Pre-post intervention











Note: Green squares denote CONSORT items are present; red square denote absent items; grey squares denote NA values for studies not of RCT design. Percentages 
are calculated for RCT designs only.






































































































































































































Appendix 4 - Outcome Assessment Instruments
The outcomes of emotional well-being, depressive symptoms and symptoms of 
anxiety were measured using a variety of assessments. As stated earlier, every test 
was publised and validated.  Each test is summarised below:
Measures for emotional well-being
Functional Assessment of Cancer Therapy - general / breast / lung / anemia 
(FACT)
FACT contains subscales that measure functional well-being, emotional well-being, 
physical well-being and social/family well-being.  Each subscale is a contained 
instrument with the score across all subscales being used to represent an index of 
quality-of-life.  Within the FACT assessment battery are additional sub-scales related
to discrete cancer diagnoses, indicated by a capital letter after the assessment 
acronym.  These scales are analysed independently of the base scales.  An change 
of two scale points is considered significant within the literature for this instrument 
(ref here)
Quality of Life Index Cancer Version III (QoLIC-V3)
This instrument asks the individual to rate their satisfaction against areas of their life 
that they consider important. There are four domains, health and functioning, 
socioeconomic, psychological/spiritual and family, comprising a total of 66 items.  
Part I of the instrument asks the individual to rate their satisfaction within each 
domain; Part II asks the individual to evaluate the importance of each scale item with
a weighted satisfaction score between Part I and II being used for analysis.  
European Organisation for Research and Treatment of Cancer Quality of Life 
Questionnaire (EORTC)
The EORTC has five functional scales: physical, role, cognitive, emotional and social
which have been demonstrated to measure disctinctive areas of a quality of life 
index. Each scale can be used independently as a measure of change.
Measures of Depressive Symptoms
Center for Epidemiologic Studies Depression Scale (CES-D)
A 20-item instrument that measures the frequency of depressive affect, somatic 
symptoms, positive affect and interpersonal relations during the previous week.  This
scale has a clinical threshold for diagnosis of levels of depression. Values greater 
than 16 indicate clinically significant symptoms within an individual.
Beck Depression Inventory (BDI)
The BDI has 21 questions. There is a total score of 63 with higher scores indicating 
increased symptoms of depression.
Measures used for both depression and anxiety outcomes
Affects Balance Scale (ABS)
An instrument of 40 emotion adjectives, for which individuals provide evaluations of 
the degree to which they experienced the emotion during the previous week. The 
ABS-depressive affect subscale was used in the study listed here.
Profile of Mood State (POMS)
POMS comprises six subscales with higher scores indicating greater negative affect.
POMS was used as a measure of both depression and anxiety within this sample of 
papers.
Depression and Anxiety Stress Scale-21 (DASS-21)
DASS-21 has three subscales of depressive, anxiety and stress items.  Individuals 
are asked to rate their evaluations against a four point Likert scale for presence and 
intensity of their symptoms over the previous seven days.
Hospital Anxiety and Depression Scale (HADS)
The HADS has two subscales that measure depression and anxiety.  Fourteen items
measure emotion states with lower scores indicating improvement.
Measures for symptoms of anxiety
Spielberger State-Trait Anxiety Inventory (STAI)
The STAI has 20 items that assesses concurrent anxiety symptoms.  Higher scores 
indicate a higher feeling of anxiety.  One study used a short form of this task.
